N4 Pharma plc (N4P) ORD GBP0.004
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
N4 Pharma Plc is a United Kingdom-based specialist pharmaceutical company. The Company is focused on developing a silica nanoparticle delivery system to improve the cellular delivery of cancer treatments and vaccines. The Company is engaged in the development and commercialization of medicines through its delivery system, Nuvec. Nuvec is a silica nanoparticle technology with a patented spiky structure designed to load, protect and deliver nucleic acids (siRNA/DNA/mRNA) intracellularly for use in gene therapy, cancer therapeutics and vaccines. Nuvec is in the pre-clinical Phase, available for licensing to pharmaceutical and biotech partners for nucleic acid product development and is designed to overcome some of the drawbacks of existing delivery systems. The Company’s wholly owned subsidiaries include N4 Pharma UK Limited.
Contact details
Important dates
General stock information
- EPIC:
- N4P
- ISIN:
- GB00BYW8QM32
- Market cap:
- £1.81 million
- Shares in issue:
- 268.78 million
- Sector:
- Software & Computer Services
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.